Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Estrogen and bones after menopause: a reappraisal of data and future perspectives..
Hormones (Athens).
(2020). Pituitary incidentalomas: a single-centre experience..
Int J Clin Pract. 65(2), 172-7.
(2011). Hypoglycemia in a patient with advanced Sezary syndrome..
Leuk Lymphoma. 50(2), 284-6.
(2009). Comparative Effect of Atorvastatin and Rosuvastatin on 25-hydroxy-Vitamin D Levels in Non-diabetic Patients with Dyslipidaemia: A Prospective Randomized Open-label Pilot Study..
Open Cardiovasc Med J. 8, 55-60.
(2014). Type 2 Diabetes Mellitus is Associated with Increased Risk of Sarcopenia: A Systematic Review and Meta-analysis..
Calcif Tissue Int. 107(5), 453-463.
(2020). Haemophilia A and B as a cause for secondary osteoporosis and increased fracture risk..
Blood Coagul Fibrinolysis. 26(6), 599-603.
(2015). Non-functioning pituitary adenomas: a single center experience..
Exp Clin Endocrinol Diabetes. 119(5), 314-9.
(2011). Should total thyroidectomies be performed by high-volume endocrine surgeons? A cost-effectiveness analysis..
Endocrine.
(2019). Spontaneous Vertebral Fractures in Males with Osteoporosis After Denosumab Discontinuation: A Report of Two Cases..
J Clin Rheumatol.
(2019). Menopausal Hormone Therapy and Cardiovascular Risk: Where are we Now?.
Curr Vasc Pharmacol. 17(6), 564-572.
(2019). Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: a meta-analysis of observational studies..
Endocrine. 74(2), 245-253.
(2021). Acromegaly: presentation, morbidity and treatment outcomes at a single centre..
Int J Clin Pract. 65(8), 896-902.
(2011). The clinical utility of bone turnover markers in the evaluation of bone disease in patients with haemophilia A and B..
Haemophilia. 20(2), 268-75.
(2014). Sarcopenia in post-menopausal women: Is there any role for vitamin D?.
Maturitas. 82(1), 56-64.
(2015). Endocrine Disease as a Cause of Cardiovascular Disease: Current Perspectives..
Curr Pharm Des. 26(43), 5547-5550.
(2020). Management of dyslipidaemias in the elderly population-A narrative review..
Maturitas. 124, 93-99.
(2019). Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experience..
Pituitary. 15(1), 25-9.
(2012). Vitamin D deficiency in patients with haemophilia: an underestimated commorbidity..
Haemophilia. 19(5), e308-10.
(2013). Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: an Endocrine Society Clinical Practice Guideline"..
J Clin Endocrinol Metab. 105(1),
(2020). The effect of monthly ibandronate on bone mineral density and bone turnover markers in patients with haemophilia A and B and increased risk for fracture..
Thromb Haemost. 110(2), 257-63.
(2013). Bone disease in patients with haemophilia A and B--where are we now?.
Haemophilia. 21(1), 1-3.
(2015).
(2014). Drug holidays in osteoporosis treatment: mind the gaps!.
Osteoporos Int. 30(12), 2523-2524.
(2019). The role of sclerostin/dickkopf-1 and receptor activator of nuclear factor kB ligand/osteoprotegerin signalling pathways in the development of osteoporosis in patients with haemophilia A and B: A cross-sectional study..
Haemophilia. 24(2), 316-322.
(2018). Bone Health in Patients with Dyslipidemias: An Underestimated Aspect..
Int J Mol Sci. 23(3),
(2022).